EUVIMEDEUVIMED entdecken
Leserbrief

Letter to the Editor on “Normal-weight MASLD: reclassification, characteristics, and adverse liver outcomes across diverse populations”

Yixuan Zhu, Jie Li

Clinical and Molecular Hepatology · 06.11.2026

DOI: 10.3350/cmh.2026.0301 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 06.11.2026. Verfasst von Yixuan Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
  • Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China. lijier@nju.edu.cn.

Zitieren

APA

Zhu, Y., & Li, J. (2026). Letter to the Editor on “Normal-weight MASLD: reclassification, characteristics, and adverse liver outcomes across diverse populations”. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0301

Vancouver

Zhu Y, Li J. Letter to the Editor on “Normal-weight MASLD: reclassification, characteristics, and adverse liver outcomes across diverse populations”. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0301

BibTeX
@article{Zhu2026,
  author = {Zhu, Yixuan and Li, Jie},
  title = {Letter to the Editor on “Normal-weight MASLD: reclassification, characteristics, and adverse liver outcomes across diverse populations”},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  doi = {10.3350/cmh.2026.0301}
}
Kostenlos starten →